Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

164.14 +2.74 (+1.70%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 Next >
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
GOP control of Congress under Trump could lead to a surge in M&A activity, especially in banks and biotech. Factors like equity market returns and rate cuts could fuel deals, with small-cap targets and... 
Via Benzinga
Topics Government
Exposures Political
Why DaVita Stock Withered on Wednesday
The company's profitability is going in the wrong direction for many investors. 
Via The Motley Fool
What Analysts Are Saying About DaVita Stock
Via Benzinga
Key Takeaways From DaVita Analyst Ratings
Via Benzinga
6 Analysts Assess DaVita: What You Need To Know
Via Benzinga
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due
This week marks a firehose of earnings from several top Buffett holdings. 
Via Investor's Business Daily
DaVita (DVA) Q3 2024 Earnings Call Transcript
DVA earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
3 Buy Rated Stocks Cruising At 52 Week Highs
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are rolling in. Let’s take a closer look at what’s been driving the bullish... 
Via Talk Markets
AdaptHealth Stock Earns RS Rating Upgrade
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81. 
Via Investor's Business Daily
3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions come rolling in. That’s been precisely the case for Intuitive Surgical,... 
Via Talk Markets
Bull Of The Day: Davita - Friday, September 6
Known to be the most volatile month for stocks, September is when many investors rebalance their portfolios to include less risky assets such as equities that provide exposure to essential healthcare... 
Via Talk Markets
Top Medical Stocks To Hedge Against The September Effect
While the Fed will likely cut interest rates in the coming weeks, September has historically been the most challenging month for stocks. Here are three top medical stocks to hedge against the September... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
The AI chipmaker has enjoyed a tremendous run-up, but its sky-high valuation means there are better stocks to buy than Nvidia. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
DaVita (DVA) Q2 2024 Earnings Call Transcript
DVA earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for patient referrals. 
Via Benzinga
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
As the late Meatloaf once sang, "Two out of three ain't bad." 
Via The Motley Fool
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on. 
Via InvestorPlace
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
Buffett no doubt likes what he's seeing with these high-flying stocks. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
Via Benzinga
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
Tandem Diabetes stock surged above a profit-taking zone on Friday, but DaVita reversed course and tumbled at the open. 
Via Investor's Business Daily
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace
DaVita (DVA) Q1 2024 Earnings Call Transcript
DVA earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology. 
Via InvestorPlace
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
These high-flying Buffett stocks could be attractive to different kinds of investors. 
Via The Motley Fool
Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses
Ford, United Airlines and megacap AI stock Nvidia were big-cap winners. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.